Ionis’ eplontersen fails primary endpoint in heart disease trial

Investing_ng | 09-07-2026 07:09pm |

Ionis’ eplontersen fails primary endpoint in heart disease trial

Related Articles

Nigeria: The Imperative Of A New Chapter Top
Senate Calls For National Summit Over Ou... Top
Food prices experienced robust increase ... Top
Understanding the new basic education cu... Top
Tinubu’s folly – Lagos is not Nigeri... Top
Ijaw Youths Seek Increased Funding For P... Top

Stay Updated with the Latest News!

Don't miss out on breaking stories and in-depth articles.

See the latest News